Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("PSA recurrence")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 21 of 21

  • Page / 1
Export

Selection :

  • and

Positive-block ratio in radical prostatectomy specimens is an independent predictor of prostate-specific antigen recurrenceMARKS, Rebecca A; HAIQUN LIN; KOCH, Michael O et al.The American journal of surgical pathology. 2007, Vol 31, Num 6, pp 877-881, issn 0147-5185, 5 p.Article

Comparison of prostate-specific antigen recurrence-free survival in a contemporary cohort of patients undergoing either radical retropubic or robot-assisted laparoscopic radical prostatectomySCHROECK, Florian R; SUN, Leon; FREEDLAND, Stephen J et al.BJU international (Papier). 2008, Vol 102, Num 1, pp 28-32, issn 1464-4096, 5 p.Article

Clinical implication of vascular endothelial growth factor T-460C polymorphism in the risk and progression of prostate cancerFUKUDA, Hisami; TSUCHIYA, Norihiko; OGAWA, Osamu et al.Oncology reports. 2007, Vol 18, Num 5, pp 1155-1163, issn 1021-335X, 9 p.Article

The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-upANTONARAKIS, Emmanuel S; ZHAOYONG FENG; TROCK, Bruce J et al.BJU international (Papier). 2012, Vol 109, Num 1, pp 32-39, issn 1464-4096, 8 p.Article

Prognostic value of CpG island hypermethylation at PTGS2, RAR-beta, EDNRB, and other gene loci in patients undergoing radical prostatectomy. CommentaryBASTIAN, Patrick J; ELLINGER, Jörg; HEUKAMP, Lukas C et al.European urology. 2007, Vol 51, Num 3, pp 665-674, issn 0302-2838, 10 p.Article

Obese African-Americans with prostate cancer (T1c and a prostate-specific antigen, PSA, level of <10 ng/mL) have higher-risk pathological features and a greater risk of PSA recurrence than non-African-AmericansCAIRE, Arthur A; LEON SUN; POLASCIK, Thomas J et al.BJU international (Papier). 2010, Vol 106, Num 8, pp 1157-1160, issn 1464-4096, 4 p.Article

Promoter hypermethylation in circulating blood cells identifies prostate cancer progressionROUPRET, Morgan; HUPERTAN, Vincent; CATTO, James W. F et al.International journal of cancer. 2008, Vol 122, Num 4, pp 952-956, issn 0020-7136, 5 p.Article

Percentage of positive biopsy cores, preoperative prostate-specific antigen (PSA) level, pT and Gleason score as predictors of PSA recurrence after radical prostatectomy : a multi-institutional outcome study in JapanYOKOMIZO, Akira; MURAI, Masaru; BABA, Shiro et al.BJU international (Papier). 2006, Vol 98, Num 3, pp 549-553, issn 1464-4096, 5 p.Article

Changes in PSA Kinetics Predict Metastasis-Free Survival in Men with PSA-Recurrent Prostate Cancer Treated With Nonhormonal Agents: Combined Analysis of 4 Phase II TrialsANTONARAKIS, Emmanuel S; ZAHURAK, Marianna L; JIANQING LIN et al.Cancer. 2012, Vol 118, Num 6, pp 1533-1542, issn 0008-543X, 10 p.Article

Prostate Cancer Outcome and Tissue Levels of Metal IonsSARAFANOV, Andrey G; TODOROV, Todor I; CENTENO, Jose A et al.The Prostate. 2011, Vol 71, Num 11, pp 1231-1238, issn 0270-4137, 8 p.Article

Is it necessary to separate clinical stage T1c from T2 prostate adenocarcinoma?ARMATYS, Sandra A; KOCH, Michael O; BIHRLE, Richard et al.BJU international (Papier). 2005, Vol 96, Num 6, pp 777-780, issn 1464-4096, 4 p.Article

Variables in predicting survival based on treating PSA-Only relapseMOUL, Judd W.Urologic oncology. 2003, Vol 21, Num 4, pp 292-304, issn 1078-1439, 13 p.Article

Long―term overall survival and metastasis―free survival for men with prostate―specific antigen― recurrent prostate cancer after prostatectomy: analysis of the Center for Prostate Disease Research National DatabaseANTONARAKIS, Emmanuel S; YONGMEI CHEN; ELSAMANOUDI, Sally I et al.BJU international (Papier). 2011, Vol 108, Num 3, pp 378-385, issn 1464-4096, 8 p.Article

Prognostic Significance of Gleason Score Discrepancies between Needle Biopsy and Radical ProstatectomyMÜNTENER, Michael; EPSTEIN, Jonathan I; HERNANDEZ, David J et al.European urology. 2008, Vol 53, Num 4, pp 767-776, issn 0302-2838, 10 p.Article

Radial distance of extraprostatic extension measured by ocular micrometer is an independent predictor of prostate-specific antigen recurrence : A new proposal for the substaging of pT3a prostate cancerSUNG, Ming-Tse; HAIQUN LIN; KOCH, Michael O et al.The American journal of surgical pathology. 2007, Vol 31, Num 2, pp 311-318, issn 0147-5185, 8 p.Article

Expression and localisation of Akt-I, Akt-2 and Akt-3 correlate with clinical outcome of prostate cancer patientsLE PAGE, C; KOUMAKPAYI, I. H; ALAM-FAHMY, M et al.British journal of cancer. 2006, Vol 94, Num 12, pp 1906-1912, issn 0007-0920, 7 p.Article

Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancerTEWARI, Ashutosh; HORNINGER, Wolfgang; PORTER, Chris et al.BJU international (Papier). 2005, Vol 96, Num 1, pp 29-33, issn 1464-4096, 5 p.Article

High tissue density of FOXP3+ T cells is associated with clinical outcome in prostate cancerFLAMMIGER, Anna; WEISBACH, Lars; HULAND, Hartwig et al.European journal of cancer (1990). 2013, Vol 49, Num 6, pp 1273-1279, issn 0959-8049, 7 p.Article

Anatomic radical retropubic prostatectomy : long-term recurrence-free survival rates for localized prostate cancerCHUN, Felix K.-H; GRAEFEN, Markus; ZACHARIAS, Mario et al.World journal of urology (Print). 2006, Vol 24, Num 3, pp 273-280, issn 0724-4983, 8 p.Article

Effect of obesity on prostate-specific antigen recurrence after radiation therapy for localized prostate cancer as measured by the 2006 radiation therapy oncology group-american society for therapeutic radiation and oncology (RTOG-ASTRO) phoenix consensus definitionSTROUP, Sean P; CULLEN, Jennifer; AUGE, Brian K et al.Cancer. 2007, Vol 110, Num 5, pp 1003-1009, issn 0008-543X, 7 p.Article

Combined low-dose flutamide plus finasteride vs low-dose flutamide monotherapy for recurrent prostate cancer: a comparative analysis of two phase II trials with a long-term follow-upBANEZ, Lionel L; BAKE, Gary W; MCLEOD, David G et al.BJU international (Papier). 2009, Vol 104, Num 3, pp 310-314, issn 1464-4096, 5 p.Article

  • Page / 1